Internet of Things and M2M Communications Blog | KORE

Decentralised Clinical Trials: Partnering to Reduce Risk

3 minute read

Contract research organisations (CROs) and pharmaceutical companies are looking to drive innovation and decentralise clinical drug trial operations through Internet of Things (IoT) technology more than ever. Decentralised...

Internet of Things and M2M Communications Blog | KORE | Connectivity

Decentralised Clinical Trials: Partnering to Reduce Risk

Maximising the Value of IoT-based Healthcare

Smart Energy Transformation: Power your Products with Global Connectivity

KORE Announces Industry-Aligned Solution Areas to Better Serve Customers

eSIM Is Critical to the IoT-Driven Future

EU Commission Guidelines for Supply Chain Management

2020 Prediction Series: eSIM Gains Traction

Top 5 Features You’ll Need in a Connectivity Management System

Which eSIM Strategy will Re-invent your IoT Program?

The eSIM Effect: A look at the Economic Impact

3 Factors to Simplifying Your LTE Migration